Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
10/2000
10/05/2000WO2000058254A1 Synthesis of epothilones
10/04/2000EP1041071A1 Methods for the preparation of coumarine derivatives
10/04/2000EP1041066A1 Steroid receptor modulator compounds and methods
10/04/2000EP1040113A1 A SCALABLE METHOD FOR THE ISOLATION OF ANTI-HIV AGENTS FROM THE TROPICAL PLANT $i(CALOPHYLLUM)
10/04/2000EP0772610B1 Dihydrobenzofuranes
10/03/2000US6127415 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
10/03/2000US6127372 Sulfonamide inhibitors of aspartyl protease
09/2000
09/28/2000WO2000056737A2 Calanolides for inhibiting btk
09/28/2000WO2000027839A9 Rameswaralide and rameswaralide derivatives
09/28/2000WO1999067417A3 Fitness assay and associated methods
09/28/2000DE19913604A1 Chirale Verbindungen und deren Verwendung als chirale Dotierstoffe zur Herstellung von cholesterisch-flüssigkristallinen Zusammensetzungen Chiral compounds and their use as chiral dopants for the production of cholesteric liquid crystal compositions
09/28/2000CA2365244A1 Calanolides for inhibiting btk
09/27/2000EP1038941A1 Chiral compounds and their use as chiral dopants for preparing cholesteric liquid crystal compositions
09/27/2000EP1038876A2 1,2-Dioxetane derivative fused to pyran ring and use thereof
09/27/2000EP1038037A1 Screening assays for the detection and diagnosis of influenza virus
09/27/2000EP1037893A1 Use of nitroethane derivatives as microbicides and specific nitroethane derivatives
09/27/2000CN1056883C Process for producing avermectins B and cultures therefor
09/27/2000CN1056849C Fungistatin derivate and its preparing method and its application in pharmacy
09/27/2000CN1056832C Fused dihydropyridine derivate, its producing process, and its pharmaceutical composition
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000054768A1 Anti-first-pass effect compounds
09/20/2000EP1036077A1 Photochromic pyrano-fused naphthopyrans
09/20/2000EP1036072A1 Thrombin receptor antagonists
09/20/2000EP1036058A1 Adamantane derivatives
09/20/2000EP1035858A1 Use of ginkgo biloba extracts for preparing a medicine
09/20/2000CN1267300A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs useful for inhibition of farnesyl protein transferase
09/20/2000CN1056612C Process for epoxidising prochiral olefins and catalyst therefor
09/19/2000US6121274 Phosphodiesterase inhibitor for treatment of respiratory system disorders
09/14/2000WO2000053175A1 Compounds and methods
09/13/2000EP1034165A1 Pyrazolylpyrazoles substituted by 1-methyl-5- alkylsulphonyl, 1-methyl-5- alkylsuphinyl and 1-methyl-5- alkylthio, methods for preparing them and use as herbicides
09/13/2000EP1033983A1 Cyclic amino acid derivatives as cell adhesion inhibitors
09/13/2000EP0641439B1 Reagents and methods for the quantification of imipramine or desipramine in biological fluids
09/13/2000EP0599935B1 Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids
09/06/2000EP1033370A1 Novel substance ft-0554 and process for producing the same
09/06/2000EP1033130A1 Urokinase production inhibitors, angiogenesis inhibitors and methods of prevention or treatment with both
09/06/2000EP1032265A1 New psoralens for pathogen inactivation
09/06/2000EP0642345B1 Halichondrins and related compounds
09/05/2000US6114568 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors
09/05/2000US6114376 Reversing agent is ll-f28249alpha-lambda series of compounds, the 23-oxo or 23-imino derivative thereof, the avermectins, the 22,23-dihydro derivatives thereof and the milbemycins
09/05/2000US6114374 2-and 2,5-substituted phenylketoenols
09/05/2000US6113812 Photochromic articles
08/2000
08/31/2000WO2000050605A1 Avermectin aglycon synthase genes
08/31/2000WO2000050423A1 C-21 modified epothilones
08/31/2000CA2363714A1 Avermectin aglycon synthase genes
08/30/2000EP0690843B1 Formyl- or cyano- substituted indole derivatives having dopaminergic activity
08/30/2000CN1265105A Novel synthesis of myo-inositol phosphates
08/29/2000US6110964 For treating arthritis, inflammatory bowel disease, crohn's disease, emphysema, acute respiratory distress syndrome, asthma chronic obstructive pulmonary disease, alzheimer's disease, organ transplant toxicity, cachexia, cancer
08/29/2000US6110872 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
08/24/2000WO2000049021A2 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/24/2000WO2000049019A2 Novel epothilone derivatives, method for producing them and their pharmaceutical use
08/24/2000DE19908765A1 New, chemically and metabolically stable 16-halo or cyano-epothilone derivatives are cell division regulators useful e.g. for treating malignant tumors or chronic inflammatory disease
08/24/2000DE19908760A1 New, chemically and metabolically stable epothilon derivatives having modified macrocyclic ring, useful e.g. for treating malignant tumors or chronic inflammatory disease, are cell division regulators
08/24/2000DE19907588A1 New C-21 modified epothilone derivatives useful for treating e.g. cancer and other proliferative diseases and inhibiting angiogenesis and inducing apoptosis
08/24/2000CA2361278A1 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/23/2000EP1028722A1 Pharmaceutically active composition containing artemisinine and/or a derivative of artemisinine
08/23/2000CN1264373A Polyglycidyl spirocompounds and their use in epoxy resins
08/22/2000US6107310 Heteroarylcarboxamide derivatives for treating CNS disorders
08/22/2000US6107254 Use in herbicidal compositions and plant-growth regulating compositions
08/22/2000US6107036 Heterocyclic dioxethane substrates, process for their preparation and their use
08/22/2000US6107024 Using 1,2-dioxetane derivative substrate in enzyme-linked assay where enzyme is linked to antigen, antibody, hapten or nucleic acid; forms aryloxide intermediate when triggered, then releases energy to form light and two carbonyl compounds
08/22/2000US6106744 Having a substituted or unsubstituted ?s? pyran ring, the 3,4 positions of which are fused to the f side of the naphtho portion of the naphthopyran, and certain substituents at the 2-position of the ?t? pyran ring.
08/17/2000WO2000047584A2 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
08/17/2000WO2000047551A2 Inhibitors of aspartyl protease
08/17/2000DE19907480A1 New epothilone derivatives, useful for treating malignant tumors such as ovarian, stomach, colon, breast and lung carcinoma, acute lymphocytic and myelocytic leukemia and chronic inflammatory diseases such as psoriasis
08/17/2000CA2360952A1 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
08/16/2000CN1263095A New tricycloacylamide compound, its preparation method and medicinal composition containing them
08/15/2000US6103940 Starting from 4-hydroxy-2,2,6-trimethylcyclohexanone
08/15/2000US6103727 Pyrimidine derivatives and methods of making and using these derivatives
08/10/2000WO2000046189A1 Sulfonamide derivatives having cyclic structures
08/09/2000EP1025104A1 7-methylidene-5-oxo-furo fused naphthopyrans
08/09/2000EP0882106B1 Coating composition comprising a bicyclo- or spiro-orthoester-functional compound
08/09/2000EP0862563B1 10-deacetyl-14beta-hydroxybaccatine iii derivatives, a process for the preparation thereof and formulations containing them
08/09/2000CN1262277A Process for extracting natural flavonoid and/or terpene lactones from plant by adsorbent
08/08/2000US6100268 Vasoconstrictive dihydrobenzopyran derivatives
08/03/2000WO2000045165A1 Methods of identifying therapeutically effective antineoplastic agents with cultured cells having intact cell membranes and corresponding products
08/03/2000WO2000044216A2 Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis
08/03/2000CA2396005A1 Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis
08/02/2000EP0885229B1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon
08/02/2000CN1261891A Optically active monomer, liquid crystalline polymer and optical element
08/02/2000CN1261602A Alcohol derivative of Triperygium wilfordii lactone and its application
08/01/2000US6096840 Gas phase polymerization process
08/01/2000US6096750 Furopyrimidines and methods of making and using the same derivatives
08/01/2000US6096692 Cylic ketals and acdtals having heat and oxidation resistance, are free from carboxylic acids forming due to hydrolysis, low in hygroscopicity, inexpensive, good insulation and compatible with hydrofluorocarbons; working fluid refrigerants
08/01/2000US6096499 Mammalian DNA primase screen and activity modulating agents
07/2000
07/27/2000WO2000043373A2 Kinase inhibitors
07/27/2000WO2000023433A8 Substituted benzopyran analogs for the treatment of inflammation
07/27/2000WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses
07/27/2000WO1999063994A9 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE
07/27/2000CA2359680A1 Kinase inhibitors
07/26/2000EP1021438A1 Trioxane dimer compounds having antiproliferative and antitumor activities
07/26/2000EP1021432A1 Halogen substituted tetracyclic tetrahydrofuran derivatives
07/26/2000EP1021426A4 Catalytic asymmetric epoxidation
07/26/2000EP1021426A1 Catalytic asymmetric epoxidation
07/26/2000EP1021414A1 Frangible compounds for pathogen inactivation
07/26/2000CN1054851C 3-aryl-pyrone derivatives and their preparing methods and uses as pesticides and herbicides
07/25/2000US6093725 Frangible compounds for pathogen inactivation
07/25/2000CA2169115C 1-¬2-(substituted vinyl)|-5h-2,3-benzodiazepine derivatives
07/20/2000WO2000042080A1 Photopolymerizable vinyl ether based monomeric formulations and polymerizable compositions which may include certain novel spiroorthocarbonates
07/20/2000WO2000042047A1 4-phenoxymethyl-substituted milbemycins
07/20/2000WO2000042046A1 Artemisinin analogs having antimalarial, antiproliferative, and antitumor activities and chemoselective methods of making the same